Scientific Program

Program Book HFSA-APAHFF.pdf (35MB)
0900 - 0905 Welcome and Introduction
Hong Fung, CEO, CUHK Medical Centre, Hong Kong SAR
SESSION I: HFSA-APAHFF 2022 Keynote Lecture

Moderators: W. H. Wilson Tang (USA), Erik Fung (Hong Kong), Bryan P. Y. Yan (Hong Kong), G. M. Tan (Hong Kong)

0905 - 0930 HFpEF Therapy in 2022: What Drug and Why?
James C. Fang (Salt Lake City, UT, USA)

Moderators: Y. S. Archie Lo (Hong Kong), Godwin T. C. Leung (Hong Kong), Mário Évora (Macau)

0930 - 0950 Get-With-The-Guidelines & GDMT: Why It Matters
Gregg C. Fonarow (Los Angeles, CA, USA)
0950 - 1010 Cardiovascular and Heart Failure Management of COVID-19: The New York Experience
Nir Uriel (New York, NY, USA)
1010 - 1030 The Clinical Examination in Patients with Heart Failure: New Insights
Mark H. Drazner (Dallas, TX, USA)

Moderators: Zaheer Yousef (Cardiff, UK), Erik Fung (Hong Kong), Michael W. Fong (Los Angeles, USA)

1030 - 1050 Novel Medical Therapies for Heart Failure and Cardiomyopathies
W. H. Wilson Tang (Cleveland, OH, USA)
1050 - 1110 The Future of Mechanical Circulatory Support
Mandeep R. Mehra (Boston, MA, USA)
1110 - 1130 Pulmonary Decongestion in Heart Failure: Who Are the High-Risk Patients
Lynne W. Stevenson (Nashville, TN, USA)

Moderators: Eugene B. Wu (Hong Kong), Yu Ho Chan (Hong Kong), Wei-Ting Wang (Taipei)

1130 - 1150 Advances in Percutaneous VAD Technology
Navin K. Kapur (Boston, MA, USA)
1150 - 1210 State-of-The-Art in Invasive Hemodynamics
Nancy K. Sweitzer (Tucson, AZ, USA)
1210 - 1230 Bridging Patients Safely from VAD to Transplant
Jennifer A. Cowger (Detroit, MI, USA)
1230 - 1330 Lunch Break
Distinguished Professorial Lecture

Moderators: Roger S. Y. Foo (Singapore), Erik Fung (Hong Kong), W. H. Wilson Tang (Cleveland, OH, USA)

1330 - 1350 Mechanisms of Heart Failure in Hypoplastic Left Heart Syndrome
Cecilia W. Lo (Pittsburgh, PA, USA)
1350 - 1500 European Heart Journal Special Session

Moderator: Timothy C. Wong (Pittsburgh, PA, USA), Ganesan Karthikeyan (New Delhi, India), Chi-Ming Chow (Toronto, ONT, Canada)

1350 - 1405 Leadership in Academic Cardiology: How to publish in the European Heart Journal
Filippo Crea (Editor-in-Chief, European Heart Journal; Rome, Italy)
1405 - 1420 Cardiac Magnetic Resonance Imaging in Heart Failure
Chiara Bucciarelli-Ducci (Deputy Editor, European Heart Journal; London, UK)
1420 - 1435 Circulating Biomarkers for Heart Failure: quo vadis?
Antoni Bayés-Genís (Barcelona, Spain)
1435 - 1450 Multimodality Cardiovascular Imaging in the Investigation of Decompensated Heart Failure in Patients with Adult Congenital Heart Disease
Kin-Shing Lun (Hong Kong)
1450 - 1500 Roundtable Discussion
1500 - 1540 SESSION III: Cardiac Transplantation in the Asia Pacific Region

Moderators: Glenn Rose Advincula (Philippines), Steven Tsui (Cambridge, UK)

SESSION IV: Cardiac Electrophysiology

Moderators: Gary C. P. Chan (Hong Kong), Cheuk Man Yu (Hong Kong)

1500 - 1510 Machine Perfusion of Donor Hearts
Peter S. Macdonald (Sydney, Australia)
Atrial Fibrillation in Heart Failure: A case for prevention
Ching Hui Sia (Singapore)
1510 - 1520 Review and Updates on Heart Transplant in South Korea: Impact of Administrative Systems Change on the Frontline
Yang Hyun Cho (S. Korea)
AF Ablation for Patients with Heart Failure
Yan Wang (Wuhan, China)
1520 - 1530 Successes and Challenges of Heart Transplantation in India Over the Past Two Decades
Sandeep Seth (New Delhi, India)
Cardiac Contractility Modulation for Advanced Heart Failure
Jo Jo Hai (Hong Kong)
1530 - 1540 Roundtable Discussion Roundtable Discussion
1540 - 1620 SESSION V: Mechanical Circulatory Support

Moderators: Goro Matsumiya (Chiba, Japan),
Cumaraswamy Sivathasan (Singapore)

SESSION VI: Pulmonary Hypertension and The Right Heart

Moderators: Edmund M. T. Lau (Sydney, Australia), Kevin K. H. Kam (Hong Kong), Toi-meng Mok (Macau), Yuichi Tamura (Tokyo, Japan)

1540 - 1550 LVAD implantations in Hong Kong
Cally K. L. Ho (Hong Kong)
The Hemodynamic Characteristics Of Severe Chronic Lung Disease Referred For Lung Transplantation In Hong Kong
Michael K. L. Wong (Hong Kong)
1550 - 1600 Destination Therapy (Durable) LVAD Program at Chiba University Hospital and in Japan
Hiroki Kohno (Chiba, Japan)
Recent controversies in initiation of drug therapy for pulmonary arterial hypertension
Edmund M. T. Lau (Sydney, Australia)
1600 - 1610 Impact of Change in UNOS Priority Listing on VAD Implantation at Keck Hospital of USC: A Perspective from Los Angeles, California
Michael W. Fong (Los Angeles, USA)
Epidemiology and Disease Management of Pulmonary Hypertension During The Last Two Decades in Japan
Yuichi Tamura (Tokyo, Japan)
1610 - 1620 Roundtable Discussion Roundtable Discussion
1620 - 1640 Tea Break
1640 - 1720 SESSION VII: Diabetic Cardiomyopathy

Moderators: Mónica Pon (Macau), Juliana C. N. Chan (Hong Kong), Alice P. S. Kong (Hong Kong)

SESSION VIII: Cardiac Rehabilitation

Moderators: Lucky R. Cuenza (Philippines), Ngai Yin Chan (Hong Kong)

1640 - 1650 miR-320 and Diabetic Cardiomyopathy
Dao Wen Wang (Wuhan, China)
Cardiac Rehab Program at National University Heart Centre, Singapore
Tee Joo Yeo (Singapore)
1650 - 1700 Human Induced Pluripotent Stem Cell Modelling for Diabetic Cardiomyopathy and its Susceptibility to SARS-CoV2 myocardial damage
David C. W. Siu (Hong Kong)
Updates on the Progress and Development of Cardiac Rehabilitation in Asia
Ngai Yin Chan (Hong Kong)
1700 - 1710 Optimal Management of Glucose and Extraglycemic Risks in Patients with Heart Failure and Diabetes
Andrea O. Y. Luk (Hong Kong)
Cardiac Rehab Program at CUHK Medical Centre
Eva Y. W. Chun (Hong Kong)
1710 - 1720 Roundtable Discussion Roundtable Discussion
1720 - 1800 SESSION IX: Cardiorenal Interactions

Moderators: Narittaya Varothai (Bangkok, Thailand), Ling Ling Ip (Hong Kong), Ka Lung Chui (Hong Kong)

SESSION X: Palliative Care

Moderators: Huei Yaw Wu (Singapore), Raymond S. K. Lo (Hong Kong), Tung Wai AuYeung (Hong Kong)

1720 - 1730 The Cardiorenal Axis, A Love-hate Relationship: Can Manipulating The Kidney Affect The Heart?
Marjorie W. Y. Foo (Singapore)
Interethnic Differences in Advance Care Planning for End-Stage Heart Failure: Practice Tips from Singapore
Shirlyn H. S. Neo (Singapore)
1730 - 1740 Diabetic Cardiomyopathy and Nephropathy: Lessons from The Hong Kong Diabetes Register
Ronald C. W. Ma (Hong Kong)
Managing Frailty in End-Stage Heart Failure
Sunita Puri (Los Angeles, CA, USA)
1740 - 1750 Intensive Volume Removal in Patients with Advanced Heart Failure and Chronic Kidney Disease: Pitfalls and Pearls
Narittaya Varothai (Bangkok, Thailand)
Inotropic Support for End-Stage Heart Failure in the Ambulatory Setting
Erik Fung (Hong Kong)
1750 - 1800 Roundtable Discussion Roundtable Discussion

* Please note that the Organizing Committee reserves the right to change the program without prior notice.